Cargando…
Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases
The detailed molecular mechanisms and safety issues of recombinant human bone morphogenetic protein-2 (rhBMP-2) usage in bone graft substitution remain poorly understood. To investigate the molecular mechanisms underlying the function of rhBMP-2 in gastric cancer cells, we used microarrays to determ...
Autores principales: | Lee, Kwang Bok, Jin, Hua, Ye, Shuai, Park, Byung Hyun, Kim, Soo Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341992/ https://www.ncbi.nlm.nih.gov/pubmed/27636990 http://dx.doi.org/10.18632/oncotarget.11969 |
Ejemplares similares
-
Computational completion of the Aurora interaction region of N-Myc in the Aurora a kinase complex
por: Altiner, Pinar, et al.
Publicado: (2023) -
Expression of aurora kinase A correlates with the Wnt‐modulator RACGAP1 in gastric cancer
por: Bornschein, Jan, et al.
Publicado: (2016) -
Comparison of recombinant human bone morphogenetic protein-2-infused absorbable collagen sponge, recombinant human bone morphogenetic protein-2-coated tricalcium phosphate, and platelet-rich fibrin-mixed tricalcium phosphate for sinus augmentation in rabbits
por: Kim, Chul-Hun, et al.
Publicado: (2017) -
Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma
por: Diaz, Roberto Jose, et al.
Publicado: (2014) -
Aurora kinase A is a possible target of OSU-03012 to destabilize MYC family proteins
por: SILVA, ANDRES, et al.
Publicado: (2014)